UnknownPhase 3

Effects of Proxelan Somministration in Patients With Chronic Prostatitis

Italy30 participantsStarted 2017-02-16

Plain-language summary

The purpose of the study is to determinate the antinflammatory effects of the Proxelan on a cohort of patients affected by prostatitis'like symptoms and clinical evidence of abacterical prostatistis, trough a significative improvements of pain symptoms according to the NIH-CPSI questionnaire items, spermatozoa motility/concentration variations and the semen cytokines level decrease.

Who can participate

Age range18 Years – 50 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- prostatitis like symptoms for at least three months Exclusion Criteria: * significant post-voidal residual volume * Meares and Stamey test suggestive for bacterial infection * neoplasms, * urinary stones, * antibiotic therapy in the previous three months, * irritable bowel syndrome, * previous radiotherapic or chemiotherapic treatment, * urethral stenosis, * neurogenic bladder * previous prostatic surgery

What they're measuring

National Institutes of Health - Chronic Prostatitis Symptom (NIH-CPS) questionnaires score

Timeframe: 30 days

Trial details

NCT IDNCT03629769

SponsorUniversity of Pisa

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-09-01

View on ClinicalTrials.gov More Chronic Prostatitis trials